Credit for this activity will be provided through October 4, 2014. There is no fee for participating in this activity.
Jointly Sponsored by the Center for Continuing and Outreach Education at Rutgers Biomedical and Health Sciences and New York/New Jersey AIDS Education and Training Center (NY/NJ AETC).
Funding for this activity is provided by the Health Resources and Services Administration (HRSA).
Physicians, Physician Assistants, Nurse Practitioners, Nurses, and other Primary Care Clinicians.
Program Description and Overall Goal
The comprehensive Cervical Pap Test Training Program for Clinical Providers was developed to provide HIV clinicians with the knowledge, skills, and support to appropriately perform cervical Pap tests and pelvic exams for HIV positive women as recommended by national guidelines, reduce the barriers for clinicians and patients associated with lower cervical Pap test rates, and ultimately, to improve clinical rates of Pap tests performed among HIV positive women.
Course Goals and Objectives
This continuing education activity is designed to enhance the ability of HIV care providers to perform cervical Pap tests and pelvic examinations.
At the conclusion of this activity, the participant should be able to:
- Describe the background, technique and interpretation of the liquid‐based cervical Pap test.
- Demonstrate the appropriate techniques in performing an internal and external vaginal exam.
- Demonstrate the appropriate technique for performing a speculum examination and obtaining a cervical cytology sample.
- Demonstrate the appropriate technique for conducting a bimanual pelvic examination.
- Demonstrate the appropriate technique for conducting a rectal-vaginal exam.
- Evaluate the clinical guidelines for cervical cancer screening in HIV-infected women.
- Summarize the procedures for follow-up and referral of abnormal cervical Pap smears in HIV-infected women.
Method of Participation
CERVICAL PAP TEST TRAINING PROGRAM
To participate in the 3-part, Cervical Pap Test Training Program for Clinical Providers, participants must complete all the components of the program listed below:
Enroll in the Cervical Pap Test Training Program for Clinical Providers, please email email@example.com. A training coordinator will contact you to schedule and plan the additional parts of the training program outlined below.
Program Brochure PDF (406k)
1. Participant completion of the online presentation on Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination.
To receive CE credit for participation in the Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination presentation participants must complete the participation survey in its entirety. The survey includes a registration page, post-test, activity evaluation form and Participant Information Form (PIF). Participants must complete the post-test at a level of 75% proficiency. After completion of the survey, participants will be able to print out a CE certificate instantly online. CLICK HERE for more information on the online Cervical Cancer Screening in HIV-Infected Women: Pap Smears and Pelvic Examination presentation.
2. Participant completion of a skills-building session with simulated patient models (1-3 hours). Program exercises will incorporate demonstration and active trainee participation to improve trainee comfort interacting with patients and delivering cervical Pap tests and pelvic examinations.
Clinical Training Preceptorship
3. Participant completion of an interactive cervical cancer screening preceptorship. The participant is involved in observation and hands-on experience with patients (4-8 Hours in 1-2 sessions) to increase on-site capacity to perform procedures.
NY/NJ AETC will offer ongoing guidance and technical assistance after completing the training as you implement cervical screenings in your clinical facility.
Credit for participation in the skills-building session and cervical cancer screening preceptorship will be documented by the training coordinator in-person at the time the training is completed. In order to meet the learning objectives and receive continuing education credits and/or certificate of participation for the FULL 3-part program, participants are required to attend the entire training program, and complete an evaluation form. A post-program follow up evaluation will be sent within 3 months after the training program.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Rutgers, The State University of New Jersey and NY/NJ AETC. Rutgers, The State University of New Jersey is accredited by the ACCME to provide continuing medical education for physicians.
Rutgers, The State University of New Jersey designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Rutgers, The State University of New Jersey Center of Continuing and Outreach Education is an approved provider of continuing nursing education by New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider Number P173-12/12-15.
This activity is awarded 11.75 contact hours. (60 minute CH)
Nurses should only claim those contact hours actually spent participating in the activity.
Katie Carroll, MPH
New York/New Jersey AETC
Kim Choma, RN, DNP, WHNP
Rutgers, The State University of New Jersey
Private Practice, Summit, NJ
Jeffrey Kwong, DNP, MPH, ANP-BC
Columbia University School of Nursing
Nina Regevik, MD, FAACP
Raritan Bay Medical Center
Natalie Roche, MD
Assistant Professor in Obstetrics, Gynecology and Women's Health
Rutgers, The State University of New Jersey
|Anna M. Haywood, RN, MSN; FXB of Rutgers, The State University of New Jersey
||Daria Boccher-Lattimore, DrPH;
NY/NJ AIDS Education and Training Center
|Dawn Slowinski, RN, BSN, MSN, PHCNS-BC; Garden State Infectious Disease Association
||Deb M. Winters, APRN‐BC, AACRN; ID Care
|Elizabeth Ward, MSJ;Center for Continuing and Outreach Education at Rutgers Biomedical and Health Sciences
||Katie Carroll, MPH;
NY/NJ AIDS Education and Training Center
|Mari Millery, PhD; NY/NJ AIDS Education and Training Center
||Nadine Nader, NY/NJ AIDS Education and Training Center
|Peter Oates, RN, MSN, ACRN, NP-C; FXB of Rutgers, The State University of New Jersey
||Shanon Levine, NY/NJ AIDS Education and Training Center
|Zeneida Cruz, MA; Raritan Bay Medical Center
Peer Review Statement
In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, CCOE has resolved all potential and real conflicts of interest through content review by a non-conflicted, qualified reviewer. This activity was peer-reviewed for relevance, accuracy of content and balance of presentation by Judith Lightfoot, DO, FACOI; Garden State Infectious Disease Associates.
In accordance with the disclosure policies of Rutgers, and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
Nina Regevik, MD, FAACP has disclosed the following relevant financial relationships: Consultant, Gilead.
Jeffrey Kwong, DNP, MPH, ANP-BC has no relevant financial relationships to disclose.
Kim Choma, RN, DNP, WHNP has no relevant financial relationships to disclose.
Natalie Roche, MD has no relevant financial relationships to disclose.
Judith Lightfoot, DO, FACOI has no relevant financial relationships to disclose.
Planning Committee members Anna M. Haywood, RN, MSN; Daria Boccher-Lattimore, DrPH; Dawn Slowinski, RN, BSN, MSN, PHCNS-BC; Deb M. Winters, APRN‐BC, AACRN; Elizabeth Ward, MSJ; Katie Carroll, MPH; Mari Millery, PhD; Nadine Nader; Shanon Levine; Peter Oates, RN, MSN, ACRN, NP-C; and Zeneida Cruz, MA; have no relevant financial relationships to disclose.
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Contact Information for Technical Questions
Please direct technical questions to Katie Carroll, firstname.lastname@example.org, NY/NJ AETC.
Provider Contact Information
Please direct content or CE related questions or concerns to Rutgers, at 973-972-4267 or email email@example.com.
The views expressed in this activity are those of the faculty.
It should not be inferred or assumed that they are expressing the views of the Health Resources and Services Administration (HRSA), or NY/NJ AETC, or Rutgers.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. Participants are urged to consult all available data on products or procedures before using them in clinical practice.
Policy on Privacy and Confidentiality
Email firstname.lastname@example.org with questions, comments, or problems.
See NY/NJ AETC disclaimer for usage guidelines.